Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Elderly Unfit Patients”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Not applicableUnknownNCT02698124
What this trial is testing

Decitabine for Chemotherapy Unfit Korean AML Patients in Real Practice

Who this might be right for
Acute Myeloid LeukemiaElderlyIntensive Chemotherapy Unfit
Ulsan University Hospital 136
Testing effectiveness (Phase 2)Study completedNCT01444716
What this trial is testing

Ofatumumab as Front-Line Therapy in Treating Elderly Participants With Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Ended earlyNCT05144009
What this trial is testing

Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
ADC Therapeutics S.A. 41
Not applicableNot Yet RecruitingNCT07476105
What this trial is testing

Geriatric-guided Care Versus Conventional Care in Elderly Unfit/Frail Patients With Diffuse Large B-cell Lymphoma in First Line Treatment

Who this might be right for
Diffuse Large B Cell LymphomaFollicular Lymphoma Grade 3B
Fondazione Italiana Linfomi - ETS 170
Testing effectiveness (Phase 2)Study completedNCT01810705
What this trial is testing

GRASPA Treatment for Patients With Acute Myeloblastic Leukemia

Who this might be right for
Acute Myeloid Leukemia
ERYtech Pharma 123
Not applicableLooking for participantsNCT05557552
What this trial is testing

Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage III
Ruijin Hospital 56
Testing effectiveness (Phase 2)Study completedNCT04351256
What this trial is testing

Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy

Who this might be right for
NSCLC, Stage III
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 51
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507760
What this trial is testing

Oral Decitabine Plus Ivosidenib as First Line for Older/Unfit Adult AML Patients

Who this might be right for
Acute Myeloid Leukemia With Gene Mutations
PETHEMA Foundation 50
Testing effectiveness (Phase 2)Study completedNCT01415011
What this trial is testing

Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
University College, London 39
Large-scale testing (Phase 3)Study completedNCT01884623
What this trial is testing

Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer

Who this might be right for
Head Neck Cancer Squamous Cell Recurrent
Gustave Roussy, Cancer Campus, Grand Paris 82
Testing effectiveness (Phase 2)Study completedNCT01576588
What this trial is testing

Rituximab in Pretreated Elderly or Unfit B-CLL Patients

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Prof. Dr. Med. Laimonas Griskevicius 25
Testing effectiveness (Phase 2)UnknownNCT03809780
What this trial is testing

Study to Demonstrate Clinical Benefit of Lenalidomide and Dexamethasone

Who this might be right for
Multiple Myeloma
Kosin University Gospel Hospital 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07207785
What this trial is testing

PirtobrUtinib as Frontline Therapy for Elderly Unfit/Frail Patient With MAntle Cell Lymphoma

Who this might be right for
Mantle Cell Lymphoma
Fondazione Italiana Linfomi - ETS 56
Testing effectiveness (Phase 2)Ended earlyNCT02495454
What this trial is testing

GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma

Who this might be right for
CD20 Positive Diffuse Large B-cell LymphomaElderly Unfit Patients
Fondazione Italiana Linfomi - ETS 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07507825
What this trial is testing

Exploratory Study of Venetoclax, Homoharringtonine, Azacitidine Plus G-CSF for Newly Diagnosed AML (VHAG)

Who this might be right for
Acute Myeloid Leukemia (AML)
First People's Hospital of Hangzhou 61
Testing effectiveness (Phase 2)UnknownNCT04541277
What this trial is testing

Combined Inhibition of PD-1 and DNA Hypomethylating Agent +/- Chemotherapy in High-risk AML or Elderly Patients With AML Who Are Unfit for Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia, in Relapsed or RefractoryAcute Myeloid Leukemia, Elderly, UnfitAcute Myeloid Leukemia With Positive Minimal Residual Disease
Chinese PLA General Hospital 55
Not applicableLooking for participantsNCT07117422
What this trial is testing

Venetoclax-Decitabine in Untreated Elderly/Unfit AML

Who this might be right for
AML, Adult
The Second Hospital of Hebei Medical University 39
Early research (Phase 1)UnknownNCT00636922
What this trial is testing

Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Bayside Health 40
Large-scale testing (Phase 3)Study completedNCT01237808
What this trial is testing

Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation

Who this might be right for
Acute Myeloid Leukemia (AML)
University of Ulm 144
Large-scale testing (Phase 3)UnknownNCT05179733
What this trial is testing

The Efficacy and Safety of ZR2 Versus R-miniCHOP in the Treatment of Unfit or Frail de Novo Diffuse Large B-cell Lymphoma Patients Aged Older Than or Equal to 70 Years

Who this might be right for
Diffuse Large B-Cell Lymphoma
Ruijin Hospital 280
Load More Results